#1
|
||||
|
||||
Âåòðÿíàÿ îñïà
Çäðàâñòâóéòå!
Ó÷óñü â Ìåäèöèíñêîì óíèâåðñèòåòå. Ñåãîäíÿ, íà ïåðâîì æå äíå ïðàêòèêè â ïåäèàòðèè áûë êîíòàêò ñ ðåá¸íêîì, êîòîðûé çàáîëåë âåòðÿíîé îñïîé . Áîëåëà ëè â äåòñòâå, íèêòî èç ðîäèòåëåé íå ïîìíèò. Âîïðîñ òàêîé: ìîæíî ëè ÷òî-òî ñäåëàòü, òèïà ýêñòðåííîé ïðîôèëàêòèêè (âðîäå ó÷èëè, ÷òî åñòü èìóíîãëîáóëèí) è ñòîèò ëè èëè ÷òî äåëàòü? |
#2
|
||||
|
||||
Ýêñòðåííàÿ ïðîôèëàêòèêà âåòðÿíîé îñïû íå ïðàêòèêóåòñÿ.
Îäíàêî, äèâëþñü ÿ íà Âàøèõ ðîäèòåëåé... |
#3
|
||||
|
||||
Öèòàòà:
ß ñìîòðþ îïòèìèñòè÷íî ïîëó÷àåòñÿ Íó ìîæåò ïðîíåñ¸ò? |
#4
|
|||
|
|||
Åñëè íà Óêðàèíå åñòü âîçìîæíîñòü ñäåëàòü ïðèâèâêó Varilrix â òå÷ 72 ÷àñîâ ïîñëå êîíòàêòà, òî ëó÷øå ñäåëàòü. Îíà ìîæåò è íå çàùèòèò Âàñ íà 100% îò âåòðÿíêè, íî íà 100% çàùèòèò îò òÿæåëîé âåòðÿíêè.  Âàøåì âîçðàñòå, ê ñîæàëåíèþ, âåòðÿíêà - äîâîëüíî òÿæåëîå çàáîëåâàíèå.
|
#5
|
|||
|
|||
Öèòàòà:
Postexposure Vaccination and Outbreak Control Data from the United States and Japan from household, hospital, and community settings indicate that varicella vaccine is effective in preventing illness or modifying varicella severity if used within 3 days, and possibly up to 5 days, of exposure (2-4). ACIP now recommends the vaccine for use in susceptible persons following exposure to varicella. If exposure to varicella does not cause infection, postexposure vaccination should induce protection against subsequent exposure. If the exposure results in infection, no evidence indicates that administration of varicella vaccine during the presymptomatic or prodromal stage of illness increases the risk for vaccine-associated adverse events. [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Òàêæå õî÷ó îòìåòèòü, ÷òî, ñîãëàñíî ðåêîìåíäàöèÿì AAP, ìåäèöèíñêèå ðàáîòíèêè, êîíòàêòèðîâàâøèå ñ áîëüíûì è íå èìåþùèå èììóíèòåòà ê âèðóñó, íå äîëæíû êîíòàêòèðîâàòü ñ äðóãèìè ïàöèåíòàìè â èíòåðâàëå 8-21 äåíü ïîñëå ýêñïîçèöèè: All susceptible exposed personnel should be furloughed or excused from patient contact from day 8 to day 21 after exposure to an infectious patient. The interval should be extended to 28 days for people who have received VZIG. |
#6
|
||||
|
||||
Áîëüøîå ñïàñèáî çà îòâåòû
Ñêàæèò, ïîæàëóñòà, à åñëè íåò òî÷íûõ äàííûõ, áîëåëà èëè íåò, òî âñ¸ ðàâíî ìîæíî ïðèâèâêó äåëàòü? |
#7
|
||||
|
||||
Âñ¸ ðàâíî ìîæíî.
|
|
#8
|
||||
|
||||
Öèòàòà:
|
#9
|
|||
|
|||
Öèòàòà:
|
#10
|
|||
|
|||
Öèòàòà:
|
#11
|
||||
|
||||
À âîò íàïðèìåð, ÿ ðàáîòàþ íà äåòñêîì ðåâìàòîëîãè÷åñêîì îòäåëåíèè, âåäó äåòåé ñ ÞÐÀ è ÑÊÂ. È òóò ó ìåíÿ, íàïðèìåð, âûðàñòàåò íà ãóáå ãåðïåñ.
Ïî èäåå, ÿ âåäü äîëæåí óéòè íà áîëüíè÷íûé. Èíòåðåñíî, à äàñò ëè ìíå ìîé òåðàïåâò èç ïîëóêëèíèêè áîëüíè÷íûé? èëè ïîøëåò ïîäàëüøå? |
#12
|
|||
|
|||
Öèòàòà:
|
#13
|
|||
|
|||
Öèòàòà:
|
#14
|
||||
|
||||
Öèòàòà:
|
#15
|
|||
|
|||
Öèòàòà:
Öèòàòà:
|